History and Physical Examination

History

Recurrent respiratory papillomatosis (RRP)is a rare disease, and adult patients may have symptoms for months or longer before the disease is recognized. Because the larynx is the most frequently affected site for both juvenile‐onset recurrent respiratory papillomatosis (JO‐RRP) and adult–onset recurrent respiratory papillomatosis (AO‐RRP), symptoms of upper airway obstruction predominate. Upper airway obstruction may be life threatening and may be the presenting symptom. Hoarseness is the most common presenting symptom. Other symptoms include the following:

Voice change
Choking episodes
Foreign body sensation in the throat
Cough
Dyspnea
Inspiratory wheeze
Stridor

Physical examination

Physical examination findings often are nonspecific. Voice change may be noted. Inspiratory wheezing, stridor, or both may develop over the trachea or the upper thorax.

Patients with JORRP commonly present with a weak cry, episodes of choking, hoarseness, or failure to thrive. Patients with AORRP present with hoarseness, choking spells, voice change, dyspnea, or a foreign body sensation in the throat.

Differential Diagnoses

Verma H, Solanki P, James M. Acoustical and perceptual voice profiling of children with recurrent respiratory papillomatosis. J Voice. 2016 Sep. 30(5):600-5. [Medline].
Kosko JR, Derkay CS. Role of cesarean section in prevention of recurrent respiratory papillomatosis--is there one?. Int J Pediatr Otorhinolaryngol. 1996 Mar. 35(1):31-8. [Medline].
Shah KV, Stern WF, Shah FK, Bishai D, Kashima HK. Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J. 1998 May. 17(5):372-6. [Medline].
Karatayli-Ozgursoy S, Bishop JA, Hillel A, Akst L, Best SR. Risk factors for dysplasia in recurrent respiratory papillomatosis in an adult and pediatric population. Ann Otol Rhinol Laryngol. 2016 Mar. 125(3):235-41. [Medline].
Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope. 1992 Jan. 102(1):9-13. [Medline].
Derkay CS. Recurrent respiratory papillomatosis. National Organization for Rare Disorders. Available at https://rarediseases.org/rare-diseases/recurrent-respiratory-papillomatosis/. 2019; Accessed: December 11, 2020.
Derkay CS, Bluher AE. Update on recurrent respiratory papillomatosis. Otolaryngol Clin North Am. 2019 Aug. 52(4):669-79. [Medline].
Derkay CS, Bluher AE. Recurrent respiratory papillomatosis: update 2018. Curr Opin Otolaryngol Head Neck Surg. 2018 Dec. 26(6):421-5. [Medline].
Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS. 2010 Jun. 118(6-7):450-4. [Medline].
Donne AJ, Keltie K, Cole H, Sims AJ, Patrick H, Powell S. Prevalence and management of recurrent respiratory papillomatosis (RRP) in the UK: cross-sectional study. Clin Otolaryngol. 2017 Feb. 42(1):86-91. [Medline].
Novakovic D, Cheng ATL, Zurynski Y, et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018 Jan 4. 217(2):208-12. [Medline].
Zur KB. Finally: lasting help for patients with recurrent respiratory papillomatosis (RRP). Pediatric Airway Update. Dec 19, 2018. Available at https://www.chop.edu/news/finally-lasting-help-patients-recurrent-respiratory-papillomatosis-rrp. Accessed: December 11, 2020.
Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, Marcus A, Unger ER. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2003 Sep. 129(9):976-82. [Medline]. [Full Text].
San Giorgi MR, van den Heuvel ER, Tjon Pian Gi RE, et al. Age of onset of recurrent respiratory papillomatosis: a distribution analysis. Clin Otolaryngol. 2016 Oct. 41(5):448-53. [Medline].
Tjon Pian Gi RE, San Giorgi MR, Slagter-Menkema L, et al. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. Head Neck. 2015 Nov. 37(11):1625-32. [Medline].
Bishai D, Kashima H, Shah K. The cost of juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2000 Aug. 126(8):935-9. [Medline].
Shapiro AM, Rimell FL, Shoemaker D, Pou A, Stool SE. Tracheotomy in children with juvenile-onset recurrent respiratory papillomatosis: the Children's Hospital of Pittsburgh experience. Ann Otol Rhinol Laryngol. 1996 Jan. 105(1):1-5. [Medline].
Fusconi M, Grasso M, Greco A, et al. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir. Acta Otorhinolaryngol Ital. 2014 Dec. 34(6):375-81. [Medline]. [Full Text].
Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope. 1998 Jun. 108(6):935-7. [Medline].
Derkay CS, Hester RP, Burke B, Carron J, Lawson L. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol. 2004 Dec. 68(12):1493-8. [Medline].
Carifi M, Napolitano D, Morandi M, Dall'Olio D. Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag. 2015. 11:731-8. [Medline]. [Full Text].
Derkay CS, Volsky PG, Rosen CA, Pransky SM, McMurray JS, Chadha NK. Current use of intralesional cidofovir for recurrent respiratory papillomatosis. Laryngoscope. 2013 Mar. 123(3):705-12. [Medline].
Best SR, Mohr M, Zur KB. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey. Laryngoscope. 2017 Oct. 127(10):2225-9. [Medline]. [Full Text].
Freed GL, Derkay CS. Prevention of recurrent respiratory papillomatosis: role of HPV vaccination. Int J Pediatr Otorhinolaryngol. 2006 Oct. 70(10):1799-803. [Medline].
Yiu Y, Fayson S, Smith H, Matrka L. Implementation of routine HPV vaccination in the management of recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2019 Apr. 128(4):309-15. [Medline].
Hocevar-Boltezar I, Maticic M, Sereg-Bahar M, et al. Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol. 2014 Dec. 271(12):3255-62. [Medline].
Chirila M, Bolboaca SD. Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol. 2014 May. 271(5):1135-42. [Medline].
Young DL, Moore MM, Halstead LA. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma. J Voice. 2015 Mar. 29(2):223-9. [Medline].
Tjon Pian Gi RE, San Giorgi MR, Pawlita M, et al. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol. 2016 Oct. 273(10):3231-6. [Medline]. [Full Text].
Wangu Z, Hsu KK. Impact of HPV vaccination on anogenital warts and respiratory papillomatosis. Hum Vaccin Immunother. 2016 Jun 2. 12(6):1357-62. [Medline]. [Full Text].

Media Gallery

A 48-year-old woman presents with inspiratory stridor, dyspnea, and hoarseness. On direct laryngoscopy, extensive respiratory papillomatosis were diagnosed as the cause of her symptoms. Courtesy of Sat Sharma, MD, and L. Garber, MD.
This adult patient was seen for hoarseness, with a history of several prior procedures for recurrent respiratory papillomatosis. A papillomatous lesion is seen along the left true vocal fold with associated reactive edema. On pathologic analysis, moderate squamous dysplasia was seen within the papilloma. Video courtesy of Vijay R Ramakrishnan, MD.

of 2

Author

Eloise M Harman, MD Staff Physician and MICU Director, Pulmonary Division, Gainesville Veterans Affairs Medical Center

Eloise M Harman, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American Medical Women's Association, American Thoracic Society, Phi Beta Kappa, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Harold L Manning, MD Professor, Departments of Medicine, Anesthesiology and Physiology, Section of Pulmonary and Critical Care Medicine, Dartmouth Medical School

Harold L Manning, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

Chief Editor

Zab Mosenifar, MD, FACP, FCCP Geri and Richard Brawerman Chair in Pulmonary and Critical Care Medicine, Professor and Executive Vice Chairman, Department of Medicine, Medical Director, Women's Guild Lung Institute, Cedars Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine

Zab Mosenifar, MD, FACP, FCCP is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, American Thoracic Society

Disclosure: Nothing to disclose.

Additional Contributors

Sat Sharma, MD, FRCPC Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba Faculty of Medicine; Site Director, Respiratory Medicine, St Boniface General Hospital, Canada

Sat Sharma, MD, FRCPC is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, World Medical Association

Disclosure: Nothing to disclose.

Acknowledgements

Medscape Reference thanks Vijay R Ramakrishnan, MD, Assistant Professor, Department of Otolaryngology, University of Colorado School of Medicine, for assistance with the video contribution to this article.

Sections Recurrent Respiratory Papillomatosis
Overview
Presentation
DDx
Workup
Treatment
Medication
Media Gallery
References

Recurrent Respiratory Papillomatosis Clinical Presentation

History and Physical Examination

History

Physical examination

References

Tables

Contributor Information and Disclosures

What would you like to print?